Hims & Hers Health (NYSE:HIMS) has taken investors on a wild ride in 2025. The stock surged nearly 200% earlier this year, reaching an all-time high by late February – only to plunge by half in ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like Ozempic and Mounjaro. That gamble has now collapsed. The Food ...

In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other AI stocks that dominate Wednesday’s worst performers. Wall Street’s major indices ...

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company ...